Hosted on MSN1mon
Actinogen Medical Calls for Shareholder Meeting Amid Promising Trial Results
YTD Price Performance: 25.00% Average Trading Volume: 258,775 Technical Sentiment Consensus Rating: Sell Current Market Cap: $60.89M For an in-depth examination of ACW stock, go to TipRanks ...
Hosted on MSN2mon
Actinogen’s Lead Drug Xanamem Gains WHO Recognition Amid Ongoing Trials
YTD Price Performance: 2400.0% Average Trading Volume: 810,100 Technical Sentiment Consensus Rating: Sell Current Market Cap: $48.12M Learn more about ACW stock on TipRanks’ Stock Analysis page.